Article Details
Retrieved on: 2021-06-09 00:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
United BioPharma obtained Taiwan FDA approval for conducting a phase I clinical trial of its UB21 product, a third-generation monoclonal anti-IgE ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here